Today  April 16 . 2021 with the support of the State Agency for the Promotion and Protection of Investments of the Kyrgyz Republic  the Medical Academy of Kyrgyzstan held negotiations with the group Russian entrepreneurs headed by N.V. Korobovsky and F.V. Dyakov with a proposal to study the effectiveness of the new Russian anticoid drug Tubotsilin based on the KSMA. 

The guests were warmly greeted by the rector of the university, professor Indira Kudaibergenova. The meeting was also attended by vice-rector for scientific and medical work Andrey Sopuev, director of the KSMA medical center Muktarbek Iskakov, acting head of the department of management and economics of pharmacy, technology of medicines named after I. prof. E.S. Matieva Sairagul Dootalieva.